Blood clots launch investigation over J&J vaccine
The Johnson & Johnson (J&J) COVID-19 vaccine is under investigation following the reports of rare (potentially dangerous) blood clots with leading pharmaceutical authorities recommending a delay in use. The Food and Drug Administration (FDA) released a joint statement with the U.S. Centers for Disease Control and Prevention (CDC) to “pause” the use of the Johnson & Johnson single-dose vaccine as they review the data of six cases of a severe and rare type of blood clot shortly after receiving the vaccine.
The recommended pause of Johnson & Johnson's vaccine, which makes up less than 5% of the recorded shots in arms in the U.S. to date, was “out of an abundance of caution,” says White House Covid-19 coordinator Jeff Zients https://t.co/IZjVQ8catD
— The Wall Street Journal (@WSJ) April 13, 2021
The six cases occurred among women patients between the ages of 18 and 48 with symptoms occurring 6 to 13 days after vaccination. These occurrences appear to be “extremely rare” while advising recipients of the J&J vaccine who experience symptoms including shortness of breath, severe headache, leg pain, or abdominal pain within three weeks of receiving the vaccine should contact their health care provider.
The White House will also be intervening in the growing issue with the J&J vaccine with the White House COVID-19 coordinator, Jeff Zients, working with federal and state partners to reschedule J&J vaccine patients to receive a Moderna or Pfizer vaccine. Johnson & Johnson disclosed in a statement they are aware of an extremely rare disorder including people with blood clots combined with low platelets in a small group of vaccine recipients.
The Biden administration is working with states to reschedule appointments for individuals who were in line to receive shots of Johnson & Johnson’s COVID-19 vaccine in the coming days. https://t.co/IRDEc9OPxt
— Michael Wilner (@mawilner) April 13, 2021
J&J maintains they’re working closely with health authorities and medical experts while supporting the open communication of this information to the public and health care professionals. J&J will also be reviewing potential cases with European health authorities and committed to proactively delay the rollout of the vaccine in Europe.
The Oxford-AstraZeneca vaccine is also experiencing similar concerns over rare blood clots with vaccines administered through the U.K., European Union (EU), and many other countries. Last week, the EU drug regulator said the benefits of the Oxford-AstraZeneca COVID-19 vaccine outweigh its risks.
Serena Williams Signs Docuseries Deal With Amazon
-
In a significant escalation of the ongoing dispute over misinformation, Brazil Supreme Court Justice Alexandre de Moraes has initiated...
-
Mumbai Takes the Throne for the Most Billionaires in Asia In a historic milestone, Mumbai has overtaken Beijing to...
-
French President Emmanuel Macron emphasized the need for Western powers to remain vigilant in the face of the Ukraine...
-
The Philippines has strongly denounced what it described as “unprovoked acts of coercion and dangerous maneuvers” by China in...
-
As Moscow Prepares to Bid Adieu, Navalny’s Funeral Raises Uncertainties and International Allegations The spokesperson for Alexei Navalny has...
-
On the two-year anniversary of the ongoing conflict between Ukraine and Russia, there is much to reflect upon. Since...
-
The Office for National Statistics (ONS) released official figures on Wednesday, revealing that the United Kingdom posted a record...
-
Greece has become the first Christian Orthodox-majority country to legalize same-sex marriage, marking a significant step forward for LGBTQ+...
-
Massive Deflation in China as CPI Plummets by 0.8% China faces mounting challenges as its consumer prices spiral deeper...
-
3 Days of Consecutive Snowing Has Wreaked Havoc on Transportation As China prepares to celebrate the Lunar New Year,...
-
Rapid Growth in Electric Cars Propels China to The Forefront of Global Vehicle Exports China has surpassed Japan as...
-
Pakistan’s Political Landscape Suffers a Shift Following Khan’s Sentencing Former Pakistani Prime Minister Imran Khan and his wife, Bushra...